Efficacy of PD-1/PD-L1 inhibitors against pretreated advanced cancer: a systematic review and meta-analysis

BACKGROUND: Programmed cell death 1 (PD-1) and programmed cell death-ligand 1(PD-L1) inhibitors have captured our attention as new therapeutic options for several tumor types. Nonetheless, the differences in efficacy between PD-1/PD-L1 inhibitors and conventional treatments (chemotherapy or targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hao, Zhu, Qian, Luo, Xian Shi, Yang, Xiong Wen, Wang, Hai Dong, Guo, Chang Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837741/
https://www.ncbi.nlm.nih.gov/pubmed/29545941
http://dx.doi.org/10.18632/oncotarget.24163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837741/
https://www.ncbi.nlm.nih.gov/pubmed/29545941
http://dx.doi.org/10.18632/oncotarget.24163

Ejemplares similares